Monitoring Adherence to Growth Hormone Treatments Using Digital Health Solutions in Hong Kong: An Expert Panel...

Area of Science:

• Endocrinology
• Digital Health
• Patient Monitoring

Background:

• Long-term management of recombinant human growth hormone (GH) therapy requires effective patient monitoring and adherence support.
• Digital health solutions offer evolving functionalities for chronic disease management, including hormone therapies.
• Healthcare professional (HCP) adoption is crucial for the successful integration of new technologies in patient care.

Purpose of the Study:

• To explore Hong Kong-based HCPs' perspectives on digital health solutions for monitoring growth hormone (GH) therapy adherence.
• To identify key features and functionalities of digital health tools that influence HCP acceptance and use.
• To inform the effective integration and recommendation of digital health solutions in GH treatment protocols.

Main Methods:

• A participatory workshop was conducted in Hong Kong.
• The workshop focused on HCPs' views regarding digital health solutions, specifically the Aluetta® with Smartdot™ and Growzen™ ecosystem.
• Qualitative insights were gathered on the practicalities of using these tools for monitoring GH therapy.

Main Results:

• HCPs' perspectives on the utility and challenges of digital health for GH therapy monitoring were documented.
• Insights into the perceived benefits and barriers to adopting digital health solutions were obtained.
• Understanding HCPs' viewpoints is essential for optimizing digital tools for patient adherence.

Conclusions:

• Digital health solutions present opportunities for enhanced management of long-term GH treatment.
• HCP insights are vital for tailoring digital health tools to improve adherence and patient outcomes in growth hormone deficiency.
• Effective integration of digital health empowers HCPs to support successful treatment strategies.